Durvalumab (D) +/- Tremelimumab (T) In Combination With Dose-Dense Mvac (Ddmvac) As Neoadjuvant Treatment In Patients With Muscle-Invasive Bladder Carcinoma (Mibc): Results Of Nemio, A Randomized Phase I-Ii Trial
Durvalumab;Tremelimumab
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: Durvalumab (D) +/- Tremelimumab (T) In Combination With Dose-Dense Mvac (Ddmvac) As Neoadjuvant Treatment In Patients With Muscle-Invasive Bladder Carcinoma (Mibc): Results Of Nemio, A Randomized Phase I-Ii Trial ### Output: Durvalumab;Tremelimumab